177 related articles for article (PubMed ID: 29762441)
1. A Risk-Stratified Comparison of High-Risk Findings in Reduction Mammoplasty.
Dreifuss SE; Landfair AS; De La Cruz C
Ann Plast Surg; 2018 Jul; 81(1):36-38. PubMed ID: 29762441
[TBL] [Abstract][Full Text] [Related]
2. Incidental Findings in Reduction Mammoplasty Specimens in Patients with No Prior History of Breast Cancer. An Analysis of 783 Specimens.
Usón Junior PLS; Callegaro Filho D; Bugano DDG; Geyer FC; de Nigro Corpa MV; Gonçalves PDS; Simon SD; Kaliks RA
Pathol Oncol Res; 2018 Jan; 24(1):95-99. PubMed ID: 28391513
[TBL] [Abstract][Full Text] [Related]
3. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers.
Desouki MM; Li Z; Hameed O; Fadare O; Zhao C
Hum Pathol; 2013 Sep; 44(9):1877-81. PubMed ID: 23656973
[TBL] [Abstract][Full Text] [Related]
4. Incidental breast carcinoma: incidence, management, and outcomes in 4804 bilateral reduction mammoplasties.
Tang R; Acevedo F; Lanahan C; Coopey SB; Yala A; Barzilay R; Li C; Colwell A; Guidi AJ; Cetrulo C; Garber J; Smith BL; Gadd MA; Specht MC; Hughes KS
Breast Cancer Res Treat; 2019 Oct; 177(3):741-748. PubMed ID: 31317348
[TBL] [Abstract][Full Text] [Related]
5. The Incidence of Occult Malignant and High-Risk Pathologic Findings in Breast Reduction Specimens.
Razavi SA; Hart AM; Betarbet U; Li X; Carlson GW; Losken A
Plast Reconstr Surg; 2021 Oct; 148(4):534e-539e. PubMed ID: 34550926
[TBL] [Abstract][Full Text] [Related]
6. Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience.
Colwell AS; Kukreja J; Breuing KH; Lester S; Orgill DP
Plast Reconstr Surg; 2004 Jun; 113(7):1984-8. PubMed ID: 15253187
[TBL] [Abstract][Full Text] [Related]
7. Incidental atypical proliferative lesions in reduction mammoplasty specimens in patients with a history of breast cancer.
Li Z; Fadare O; Hameed O; Zhao C; Desouki MM
Hum Pathol; 2014 Jan; 45(1):104-9. PubMed ID: 24182561
[TBL] [Abstract][Full Text] [Related]
8. Incidental breast carcinoma in reduction mammoplasty.
Huysmans M; Bronckaers M; Schillebeeckx C; Servaes D
Acta Chir Belg; 2017 Oct; 117(5):308-311. PubMed ID: 28610472
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic mastectomy: pathologic findings in high-risk patients.
Khurana KK; Loosmann A; Numann PJ; Khan SA
Arch Pathol Lab Med; 2000 Mar; 124(3):378-81. PubMed ID: 10705389
[TBL] [Abstract][Full Text] [Related]
10. Recommendations for Pathologic Evaluation of Reduction Mammoplasty Specimens: A Prospective Study With Systematic Tissue Sampling.
Ambaye AB; Goodwin AJ; MacLennan SE; Naud S; Weaver DL
Arch Pathol Lab Med; 2017 Nov; 141(11):1523-1528. PubMed ID: 28795842
[TBL] [Abstract][Full Text] [Related]
11. Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions.
Acevedo F; Armengol VD; Deng Z; Tang R; Coopey SB; Braun D; Yala A; Barzilay R; Li C; Colwell A; Guidi A; Cetrulo CL; Garber J; Smith BL; King T; Hughes KS
Breast Cancer Res Treat; 2019 Jan; 173(1):201-207. PubMed ID: 30238276
[TBL] [Abstract][Full Text] [Related]
12. Proliferative Lesions Found at Reduction Mammaplasty: Incidence and Implications in 995 Breast Reductions.
Mastroianni M; Lin A; Hughes K; Colwell AS
Plast Reconstr Surg; 2019 Feb; 143(2):271e-275e. PubMed ID: 30489497
[TBL] [Abstract][Full Text] [Related]
13. A Comparative Retrospective Analysis of Complications After Oncoplastic Breast Reduction and Breast Reduction for Benign Macromastia: Are These Procedures Equally Safe?
Imahiyerobo TA; Pharmer LA; Swistel AJ; Talmor M
Ann Plast Surg; 2015 Oct; 75(4):370-5. PubMed ID: 24691307
[TBL] [Abstract][Full Text] [Related]
14. Do larger reductions yield larger returns? patient-reported outcomes as a function of specimen weight in bilateral reduction mammoplasty.
Yao A; LaFontaine S; Sultan SM; Rizzo AM; Draper L; Benacquista T; Weichman KE
J Plast Reconstr Aesthet Surg; 2021 Oct; 74(10):2537-2549. PubMed ID: 33893055
[TBL] [Abstract][Full Text] [Related]
15. Reduction mammoplasty is beneficial in women with and without history of breast cancer.
Desouki MM
Womens Health (Lond); 2015 Jul; 11(4):419-22. PubMed ID: 26245153
[No Abstract] [Full Text] [Related]
16. Early complications of a reduction mammoplasty technique in the treatment of macromastia with or without breast cancer.
Gulcelik MA; Dogan L; Camlibel M; Karaman N; Kuru B; Alagol H; Ozaslan C
Clin Breast Cancer; 2011 Dec; 11(6):395-9. PubMed ID: 21993009
[TBL] [Abstract][Full Text] [Related]
17. Incidence of occult contralateral carcinomas of the breast following mastoplasty aimed at symmetrization.
Sorin T; Fyad JP; Pujo J; Colson T; Bordes V; Leroux A; Marchal F; Brix M; Simon E; Verhaeghe JL; Classe JM; Dolivet G
Ann Chir Plast Esthet; 2014 Apr; 59(2):e21-8. PubMed ID: 24530086
[TBL] [Abstract][Full Text] [Related]
18. Frequency of clinically occult intraepithelial and invasive neoplasia in reduction mammoplasty specimens: a study of 516 cases.
Dotto J; Kluk M; Geramizadeh B; Tavassoli FA
Int J Surg Pathol; 2008 Jan; 16(1):25-30. PubMed ID: 18203780
[TBL] [Abstract][Full Text] [Related]
19. Reduction mammoplasty in adolescents and elderly: A ten year case series analyzing age related outcome with focus on safety and complications.
Wirthmann AE; Welsch L; Wellenbrock SV; Kasper L; Schlosshauer T; Bozkurt A; Hüttinger S; Rieger UM
J Plast Reconstr Aesthet Surg; 2018 Mar; 71(3):377-383. PubMed ID: 29066061
[TBL] [Abstract][Full Text] [Related]
20. Histopathological findings obtained from reduction mammoplasty specimens.
Albayrak A; Mesci CG; Güler G
Turk J Med Sci; 2015; 45(6):1374-9. PubMed ID: 26775397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
